
Thomas Sweeney Heard
Examiner (ID: 8001, Phone: (571)272-2064 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 1286 |
| Issued Applications | 710 |
| Pending Applications | 90 |
| Abandoned Applications | 491 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9670391
[patent_doc_number] => 20140234253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'Combination Treatments For Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 14/240420
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 29394
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240420 | Combination Treatments For Hepatitis C | Aug 23, 2012 | Abandoned |
Array
(
[id] => 10090226
[patent_doc_number] => 09127038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-08
[patent_title] => 'Kisspeptide-pentasaccharide conjugates'
[patent_app_type] => utility
[patent_app_number] => 14/236694
[patent_app_country] => US
[patent_app_date] => 2012-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12933
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236694
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236694 | Kisspeptide-pentasaccharide conjugates | Jul 31, 2012 | Issued |
Array
(
[id] => 9857344
[patent_doc_number] => 20150037362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-05
[patent_title] => 'MODULATORS OF ANTIVIRAL SIGNALING PATHWAYS AND THERAPEUTIC USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/234305
[patent_app_country] => US
[patent_app_date] => 2012-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21688
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14234305
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/234305 | Modulators of antiviral signaling pathways and therapeutic uses thereof | Jul 22, 2012 | Issued |
Array
(
[id] => 10141130
[patent_doc_number] => 09173917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug'
[patent_app_type] => utility
[patent_app_number] => 13/547430
[patent_app_country] => US
[patent_app_date] => 2012-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5631
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547430
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/547430 | Methods for reducing oxidative stress in a cell with a sulfhydryl protected glutathione prodrug | Jul 11, 2012 | Issued |
Array
(
[id] => 9620895
[patent_doc_number] => 08791066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-29
[patent_title] => 'Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1]'
[patent_app_type] => utility
[patent_app_number] => 13/541185
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41446
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541185
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/541185 | Branched PEG remodeling and glycosylation of glucagon-like peptide-1 [GLP-1] | Jul 2, 2012 | Issued |
Array
(
[id] => 10516000
[patent_doc_number] => 09243038
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-01-26
[patent_title] => 'Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/130336
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 22
[patent_no_of_words] => 33721
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130336
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/130336 | Macrocyclic insulin-degrading enzyme (IDE) inhibitors and uses thereof | Jun 28, 2012 | Issued |
Array
(
[id] => 10031438
[patent_doc_number] => 09072738
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity'
[patent_app_type] => utility
[patent_app_number] => 14/129734
[patent_app_country] => US
[patent_app_date] => 2012-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 12
[patent_no_of_words] => 17163
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129734
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/129734 | Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity | Jun 26, 2012 | Issued |
Array
(
[id] => 9517780
[patent_doc_number] => 20140154272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'COMPOUND AND METHOD FOR MODULATING OPIOID RECEPTOR ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/128800
[patent_app_country] => US
[patent_app_date] => 2012-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12525
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 45
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14128800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/128800 | Compound and method for modulating opioid receptor activity | Jun 21, 2012 | Issued |
Array
(
[id] => 9401705
[patent_doc_number] => 08691757
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-08
[patent_title] => 'Hepatitis C virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/492982
[patent_app_country] => US
[patent_app_date] => 2012-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26825
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13492982
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/492982 | Hepatitis C virus inhibitors | Jun 10, 2012 | Issued |
Array
(
[id] => 9635400
[patent_doc_number] => 20140213509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-31
[patent_title] => 'BETA-HAIRPIN PEPTIDOMIMETICS AS CXC4 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/124508
[patent_app_country] => US
[patent_app_date] => 2012-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14032
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14124508
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/124508 | Beta-hairpin peptidomimetics as CXC4 antagonists | Jun 5, 2012 | Issued |
Array
(
[id] => 15280039
[patent_doc_number] => 10512669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-24
[patent_title] => Blockade of inflammatory proteases with cyclic peptides
[patent_app_type] => utility
[patent_app_number] => 13/486548
[patent_app_country] => US
[patent_app_date] => 2012-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12276
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13486548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/486548 | Blockade of inflammatory proteases with cyclic peptides | May 31, 2012 | Issued |
Array
(
[id] => 8382203
[patent_doc_number] => 20120225829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'METHOD OF PRODUCING FR901228'
[patent_app_type] => utility
[patent_app_number] => 13/473633
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3224
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473633
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473633 | Method of producing FR901228 | May 16, 2012 | Issued |
Array
(
[id] => 8807982
[patent_doc_number] => 08445634
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-21
[patent_title] => 'Method of producing FR901228'
[patent_app_type] => utility
[patent_app_number] => 13/473635
[patent_app_country] => US
[patent_app_date] => 2012-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 3204
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13473635
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/473635 | Method of producing FR901228 | May 16, 2012 | Issued |
Array
(
[id] => 8701701
[patent_doc_number] => 08394923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-12
[patent_title] => 'Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses'
[patent_app_type] => utility
[patent_app_number] => 13/470130
[patent_app_country] => US
[patent_app_date] => 2012-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 8353
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13470130
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/470130 | Apparatus and method for separation of liquid phases of different density and for fluorous phase organic syntheses | May 10, 2012 | Issued |
Array
(
[id] => 8617316
[patent_doc_number] => 20130022628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-24
[patent_title] => 'ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM'
[patent_app_type] => utility
[patent_app_number] => 13/465933
[patent_app_country] => US
[patent_app_date] => 2012-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 119
[patent_no_of_words] => 56042
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13465933
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/465933 | ACYL PSEUDOPEPTIDES WHICH CARRY A FUNCTIONALIZED AUXILIARY ARM | May 6, 2012 | Abandoned |
Array
(
[id] => 9020422
[patent_doc_number] => 08530407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-10
[patent_title] => 'Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress'
[patent_app_type] => utility
[patent_app_number] => 13/455155
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 13164
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13455155
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/455155 | Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress | Apr 24, 2012 | Issued |
Array
(
[id] => 9464035
[patent_doc_number] => 20140128462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/113768
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14844
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113768
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113768 | LYOPHILIZED PREPARATION OF CYTOTOXIC DIPEPTIDES | Apr 24, 2012 | Abandoned |
Array
(
[id] => 8348076
[patent_doc_number] => 20120208995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION'
[patent_app_type] => utility
[patent_app_number] => 13/450885
[patent_app_country] => US
[patent_app_date] => 2012-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 115823
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13450885
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/450885 | Macrocyclic inhibitors of hepatitis C virus replication | Apr 18, 2012 | Issued |
Array
(
[id] => 9491625
[patent_doc_number] => 20140142031
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'CYCLIC PEPTIDE FROM NONOMURAEA SP., PROCESS FOR THE PRODUCTION THEREOF, AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF MYCOBACTERIA RELATED DISEASE COMPRISING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/112720
[patent_app_country] => US
[patent_app_date] => 2012-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12691
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112720
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112720 | Cyclic peptide from Nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same | Apr 17, 2012 | Issued |
Array
(
[id] => 10540672
[patent_doc_number] => 09265774
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders'
[patent_app_type] => utility
[patent_app_number] => 14/112016
[patent_app_country] => US
[patent_app_date] => 2012-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32527
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112016
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112016 | Methods, compounds and pharmaceutical compositions for treating anxiety and mood disorders | Apr 12, 2012 | Issued |